Eric Leire
CEO Genflow Biosciences
Dr. Eric Leire is the CEO of Genflow Biosciences, a longevity gene therapy biotech listed on the London Stock Exchange. He also serves as the executive chairman of Immunethep (virulence company) and as NED for Pherecydes (anti-infective), BSIM Therapeutics (CNS) and Inhatarget (oncology).
He brings to biotech companies
• Pharma experience: Pfizer, Schering Plough, Pharmacia
• Biotech experience: CEO of several private and public (Nasdaq, OTC.QB, OMX Nasdaq) successful biotech companies (listed ENOB on Nasdaq with $350 M market cap); Partner at the BioStrategies Group
• Academic experience: Research Associate at the Harvard AIDS Institute
• Private Equity experience: Partner at Biofund Venture Capital
He holds an MD from Grenoble University and an MBA from HEC and Kellogg School of Management, Northwestern University. He is also the inventor of several patents in the pharmaceutical field.
